Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medicenna Therapeutics Corp (MDNA.TO)

Medicenna Therapeutics Corp (MDNA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: Medicenna Therapeutics Corp

Announced today that two posters will be presented at the American Association for Cancer Research Annual ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Today announced the first patient dosed in the combination arm of the Phase 1/2 ABILITY (ABeta-only ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Today announced initiation of enrollment in the combination arm of the Phase 1/2 ABILITY (ABeta-only ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Announced that a poster presentation and an oral summary highlighting longer term follow up results ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Received a Staff Delisting Determination from the Listing Qualifications Department of the NASDAQ Stock ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Today announced dosing of the first patient in the Phase 2 monotherapy dose expansion portion of the ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Will present preclinical results featuring its MDNA223 BiSKIT candidate at the 2023 AACR Special Conference ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Announced today the appointment of Brent Meadows, MBA, as its Chief Business Officer, as part of the ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Announced a clinical update on the monotherapy dose escalation portion of the first-in-human, Phase ...

MDNA.TO : 2.08 (+23.44%)
Stocks in play: Medicenna Therapeutics Corp.

Today announced financial results and corporate highlights for the first quarter ended June 30, 2023. ...

MDNA.TO : 2.08 (+23.44%)

Barchart Exclusives

Earn While You Sleep? 3 Dividend Stocks for Reliable Passive Income
Enbridge, Coca-Cola, and Energy Transfer are three stocks that look like compelling options for investors seeking worry-free dividend income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar